HRV Pharma Partners with Haleos Labs to Develop Orphan Drugs and Niche APIs

HRV Global Life Sciences (HRV Pharma) and Haleos Labs Limited have entered into a multi-year strategic partnership aimed at accelerating the development of orphan drugs and niche active pharmaceutical ingredients (APIs). HRV Pharma, recognized as India’s first integrated Virtual API and Pharmtech company, announced the collaboration with Haleos Labs, formerly known as SMS LifeSciences. The alliance focuses on leveraging their combined expertise in contract development and manufacturing organization (CDMO) services to address specialized pharmaceutical needs.

The partnership seeks to streamline processes for developing rare disease treatments and niche APIs by combining HRV Pharma’s virtual API capabilities with Haleos Labs’ manufacturing expertise. Both companies aim to enhance efficiency in drug development while addressing unmet medical needs in the market. This collaboration marks a significant step in advancing pharmaceutical innovation through strategic alliances within the industry.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: January 21, 2026

Author

GOAI